ABT-147 is a humanized IgG1 monoclonal antibody inhibitor targeting IL-12. It is utilized in researching autoimmune diseases such as rheumatoid arthritis (RA), inflammatory diseases like inflammatory bowel disease (IBD), and other conditions including asthma.
Target-Kategorie:
Interleukin
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
